Novel N Chegou (PhD) is an Associate Professor, and co-leads the diagnostic biomarker research efforts of the Immunology Research Group. He was trained as a Medical Laboratory Scientist at the Faculty of Health Sciences, University of Buea, in Cameroon after which he joined the University and completed his postgraduate and postdoctoral studies in the field of Tuberculosis Immunology, under Prof Gerhard Walzl.
Prof Chegou's research work mainly focuses on the discovery of biomarkers for the diagnosis of tuberculosis disease and monitoring of the response to treatment. He is particularly interested in the development of simple field-friendly point-of-care diagnostics for the rapid diagnosis of tuberculosis as well as monitoring of the response to treatment in resource-constrained settings. The group conducts research in both adults and children and in both pulmonary and extrapulmonary TB. Prof Chegou is a South African National Research Foundation (NRF) rated scientist.
immunology of Mycobacterium tuberculosis infection. Prof Chegou’s group
is currently working on projects focusing on the discovery of biomarkers for
the diagnosis of tuberculosis disease, biomarkers of protective immunity
against Mycobacterium tuberculosis, biomarkers for monitoring of the
response to TB treatment and other tuberculosis/related disease projects,
including animal models.